Form D · Pharmaceuticals
Trigr Therapeutics, Inc.
Irvine, CA · CIK 0001772165
Offering snapshot reported Apr 25, 2019 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $5M Reported outside-investor minimum
- First sale
- Mar 15, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2019 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Apr 25, 2019 | Initial | $5,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-338106
There was one single purchaser for the entire $5,000,000 Offering.
Source: Form D, filed Apr 25, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Miranda Toledano | Director, Executive |
| George Uy | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
53 Carrington
Irvine, CA, 92620
Irvine, CA, 92620